Clinical Trial Update: Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating a personalized vaccine for patients with smoldering multiple myeloma has completed. The record indicates the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Smoldering Plasma Cell Myeloma | EARLY_Phase 1 | Status: COMPLETED